Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway ; volume:18 ; number:1 ; day:14 ; month:3 ; year:2023 ; pages:1-16 ; date:12.2023
Chinese medicine ; 18, Heft 1 (14.3.2023), 1-16, 12.2023
- Urheber
-
Su, ShiJie
Chen, Gongcan
Gao, Minghuang
Zhong, Guangcheng
Zhang, Zerong
Wei, Dongyun
Luo, Xue
Wang, Qi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13020-023-00722-y
- URN
-
urn:nbn:de:101:1-2023080421173356936211
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Su, ShiJie
- Chen, Gongcan
- Gao, Minghuang
- Zhong, Guangcheng
- Zhang, Zerong
- Wei, Dongyun
- Luo, Xue
- Wang, Qi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease
Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease
A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease
Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway
Alzheimer’s Disease
Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease
Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease
A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease
Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway
Alzheimer’s Disease
Acacetin improves cognitive function of APP/PS1 Alzheimer’s disease model mice via the NLRP3 inflammasome signaling pathway
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer’s disease
Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer’s Disease
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease
A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease
Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway
Alzheimer’s Disease